Form 8-K - Current report:
SEC Accession No. 0001564590-21-012047
Filing Date
2021-03-10
Accepted
2021-03-10 16:02:47
Documents
14
Period of Report
2021-03-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K flxn-8k_20210310.htm   iXBRL 8-K 36295
2 EX-99.1 flxn-ex991_24.htm EX-99.1 102280
3 GRAPHIC gcnfyp40jlqb000001.jpg GRAPHIC 13811
  Complete submission text file 0001564590-21-012047.txt   300815

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA flxn-20210310.xsd EX-101.SCH 5804
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE flxn-20210310_lab.xml EX-101.LAB 19469
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE flxn-20210310_pre.xml EX-101.PRE 11651
7 EXTRACTED XBRL INSTANCE DOCUMENT flxn-8k_20210310_htm.xml XML 3556
Mailing Address 10 MALL ROAD SUITE 301 BURLINGTON MA 01803
Business Address 10 MALL ROAD SUITE 301 BURLINGTON MA 01803 (781) 305-7777
Flexion Therapeutics Inc (Filer) CIK: 0001419600 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36287 | Film No.: 21729657
SIC: 2834 Pharmaceutical Preparations